Medpace Holdings, Inc. MEDP
NASDAQ
| 09/30/2026 | 06/30/2026 | ||||
|---|---|---|---|---|---|
| Revenue | 1.23% | 0.10% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 1.23% | 0.10% | |||
| Cost of Revenue | 1.13% | 2.16% | |||
| Gross Profit | 1.26% | -0.70% | |||
| SG&A Expenses | 7.61% | 0.39% | |||
| Depreciation & Amortization | -1.94% | -2.84% | |||
| Other Operating Expenses | -5.24% | -2.84% | |||
| Total Operating Expenses | -1.79% | -0.81% | |||
| Operating Income | 12.75% | 3.76% | |||
| Income Before Tax | 12.69% | 2.76% | |||
| Income Tax Expenses | 10.38% | 27.74% | |||
| Earnings from Continuing Operations | 13.26% | -2.02% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 13.26% | -2.02% | |||
| EBIT | 12.75% | 3.76% | |||
| EBITDA | 12.11% | 3.45% | |||
| EPS Basic | 14.21% | -1.08% | |||
| Normalized Basic EPS | 13.63% | 3.75% | |||
| EPS Diluted | 13.88% | -0.70% | |||
| Normalized Diluted EPS | 13.41% | 4.23% | |||
| Average Basic Shares Outstanding | -0.83% | -0.95% | |||
| Average Diluted Shares Outstanding | -0.64% | -1.41% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||